Sign in

    Peter Ruggiere

    Managing Director at Dawson James

    Peter Ruggiere is a Managing Director at Dawson James Securities, specializing in equity research coverage of biotechnology and healthcare companies. He provides in-depth analysis of micro-cap firms in sectors ranging from oncology to gene therapy, drawing on extensive experience and deep sector knowledge. Ruggiere has been with Dawson James for several years, leveraging a previous background in finance and investment analysis to support both institutional and retail clients. He holds professional FINRA credentials and is actively registered as a broker, demonstrating industry-standard proficiency and compliance.

    Peter Ruggiere's questions to Ocean Power Technologies (OPTT) leadership

    Peter Ruggiere's questions to Ocean Power Technologies (OPTT) leadership • Q4 2024

    Question

    Peter Ruggiere of Dawson James posed several questions regarding the company's work in oil and gas, the power generation improvements in the new PowerBuoys, the biggest market opportunity, fluctuations in the sales pipeline, gross margin levels, and the scope of the $12.5 million guidance for fiscal 2025.

    Answer

    CEO Dr. Philipp Stratmann explained that the company now targets the oil and gas sector through service providers, which accelerates sales. He detailed that next-generation buoys have higher power output due to the addition of solar and wind capabilities. He identified defense and security as a major market, with significant application overlap in offshore energy. Dr. Stratmann noted the pipeline is healthy at $85 million and fluctuates as deals convert to backlog. He confirmed gross margins have stabilized around 50-55% and positioned the $12.5 million guidance as a sustainable growth target.

    Ask Fintool Equity Research AI